Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,670.00
+65.00 (2.50%)
At close: Aug 4, 2025, 3:30 PM KST

Squarespace Market Cap

Genome & Company has a market cap or net worth of 81.29 billion as of August 8, 2025. Its market cap has decreased by -34.18% in one year.

Market Cap
81.29B
Enterprise Value
87.28B
Revenue
29.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
$2,670.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 81.29B, an increase of 13.09%. That is a compound annual growth rate of 1.88%.

History

DateMarket Cap% Change
Aug 8, 202581.29B-4.60%
Dec 30, 202485.21B-51.64%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 20201,048.46B224.28%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 26, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition